.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,633,015

« Back to Dashboard

Summary for Patent: 5,633,015

Title: Beads having a core coated with an antifungal and a polymer
Abstract:The present invention is concerned with beads comprising a 25-30 mesh core, a coating of a hydrophilic polymer and an antifungal agent, and a seal outer coating layer; pharmaceutical dosage forms comprising said beads and a method of preparing said beads. Preferred antifungal agents are lipophilic azole antifungals, such as itraconazole and saperconazole.
Inventor(s): Gilis; Paul M. V. (B-2340-Beerse, BE), De Conde ; Valentin F. V. (B-3920-Lommel, BE), Vandecruys; Roger P. G. (B-2260-Westerlo, BE)
Assignee:
Application Number:08/432,188
Patent Claim Types:
see list of patent claims
Dosage form;
Patent PDF download available with subscription

No matches for this query

Foreign Priority and PCT Information for Patent: 5,633,015

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
92202664.6Sep 03, 1992
PCT Information
PCT FiledAugust 27, 1993PCT Application Number:PCT/EP93/02327
PCT Publication Date:March 17, 1994PCT Publication Number: WO94/05263

International Patent Family for Patent: 5,633,015

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO)444<disabled in preview>
African Regional IP Organization (ARIPO)9300563<disabled in preview>
Austria145327<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc